From October 1, 2021 to December 31, 2021, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for $0 million under the buyback announced on February 25, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
77.48 USD | -0.40% | -1.77% | +36.50% |
05-31 | Roth MKM Upgrades LeMaitre Vascular to Buy Rating With $100 Price Target | MT |
05-10 | Tranche Update on LeMaitre Vascular, Inc.'s Equity Buyback Plan announced on February 27, 2024. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.50% | 1.75B | |
+9.48% | 221B | |
+13.72% | 198B | |
+23.79% | 148B | |
+33.39% | 112B | |
+4.75% | 66.85B | |
+15.59% | 52.84B | |
+3.16% | 50.86B | |
-4.35% | 38.75B | |
-1.27% | 35.15B |
- Stock Market
- Equities
- LMAT Stock
- News LeMaitre Vascular, Inc.
- Tranche Update on LeMaitre Vascular, Inc.'s Equity Buyback Plan announced on February 25, 2021.